Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Minerva Endocrinologica|February 12, 2009
The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastasesJ M H De Klerk, W J G OyenMolecular Imaging and Biology|May 23, 2014
Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translationS Lütje, M Rijpkema, W Helfrich, et al.The British Journal of Surgery|March 2, 2005
Radioimmunotherapy and colorectal cancerM J Koppe, R P Bleichrodt, W J G Oyen, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|November 23, 2006
From anatomical to biological target volumes: the role of PET in radiation treatment planningD A X Schinagl, J H A M Kaanders, W J G OyenMethods (San Diego, Calif.)|March 26, 2009
New targeted probes for radioimaging of angiogenesisT H Stollman, T J M Ruers, W J G Oyen, et al.Current Pharmaceutical Design|September 24, 2004
Development and clinical application of peptide-based radiopharmaceuticalsM Gotthardt, O C Boermann, T M Behr, et al.Annals of the Rheumatic Diseases|August 19, 2003
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritisP Barrera, W J G Oyen, O C Boerman, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 28, 2007
Imaging of infectious diseases using [18F] fluorodeoxyglucose PETC P Bleeker-Rovers, F J Vos, F H M Corstens, et al.European Journal of Cancer (Oxford, England : 1990)|January 29, 2016
A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patientsV R Bollineni, G M Kramer, E P Jansma, et al.Current Pharmaceutical Design|December 17, 2008
Receptor binding ligands to image infectionM Chianelli, O C Boerman, G Malviya, et al.Pageof 8